Kaiwen Wang

Kaiwen Wang

Auto-generated profile, based on publicly available information

Kaiwen Wang

Department of Statistics and Data Science, Southern Methodist University, Dallas, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
KWKaiwen Wang
Kaiwen Wang
YYYuqiu Yang
Yuqiu Yang
FWFangjiang Wu
Fangjiang Wu
BSBing Song
Bing Song
XWXinlei Wang
Xinlei Wang
TWTao Wang
Tao Wang
While experimental and informatic techniques around single cell sequencing (scRNA-seq) are advanced, research around mass cytometry (CyTOF) data analysis has severely lagged behind. CyTOF data are notably different from scRNA-seq data in many aspects. This calls for the evaluation and development of computational methods specific for CyTOF data. Dimension reduction (DR) is one of the critical steps of single cell data analysis. Here, we benchmark the performances of 21 DR methods on 110 real and 425 synthetic CyTOF samples. We find that less well-known methods like SAUCIE, SQuaD-MDS, and scvis are the overall best performers. In particular, SAUCIE and scvis are well balanced, SQuaD-MDS excels at structure preservation, whereas UMAP has great downstream analysis performance. We also find that t-SNE (along with SQuad-MDS/t-SNE Hybrid) possesses the best local structure preservation. Nevertheless, there is a high level of complementarity between these tools, so the choice of method should depend on the underlying data structure and the analytical needs.

4 May 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
KWKaiwen Wang
Kaiwen Wang
YYYuqiu Yang
Yuqiu Yang
YXYusen Xia
Yusen Xia
Guanghua XiaoGuanghua Xiao
Guanghua Xiao
JLJohan Lim
Johan Lim
XWXinlei Wang
Xinlei Wang
With the rise of large-scale genomic studies, large gene lists targeting important diseases are increasingly common. While evaluating each study individually gives valuable insights on specific samples and study designs, the wealth of available evidence in the literature calls for robust and efficient meta-analytic methods. Crucially, the diverse assumptions and experimental protocols underlying different studies require a flexible but rigorous method for aggregation. To address these issues, we propose BiGER, a Bayesian rank aggregation method for the inference of latent global rankings. Unlike existing methods in the field, BiGER accommodates mixed gene lists with top-ranked and top-unranked genes as well as bottom-tied and missing genes, by design. Using a Bayesian hierarchical framework combined with variational inference, BiGER efficiently aggregates large-scale gene lists, consistently achieving state-of-the-art accuracy, while providing valuable insights into source-specific reliability for researchers. Through both simulated and real datasets, we show that BiGER is a useful tool for reliable meta-analysis in genomic studies.

27 April 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
KWKaiwen Wang
Kaiwen Wang
YYYuqiu Yang
Yuqiu Yang
FWFangjiang Wu
Fangjiang Wu
BSBing Song
Bing Song
XWXinlei Wang
Xinlei Wang
TWTao Wang
Tao Wang
While experimental and informatic techniques around single cell sequencing (scRNA-seq) are advanced, research around mass cytometry (CyTOF) data analysis has severely lagged behind. CyTOF data are dramatically different from scRNA-seq data in many aspects. This calls for the evaluation and development of computational methods specific for CyTOF data. Dimension reduction (DR) is one of the critical steps of single cell data analysis. Here, we benchmark the performances of 21 DR methods on 110 real and 425 synthetic CyTOF samples. We find that less well-known methods like SAUCIE, SQuaD-MDS, and scvis are the overall best performers. In particular, SAUCIE and scvis are well balanced, SQuaD-MDS excels at structure preservation, whereas UMAP has great downstream analysis performance. We also find that t- SNE (along with SQuad-MDS/t-SNE Hybrid) possesses the best local structure preservation. Nevertheless, there is a high level of complementarity between these tools, so the choice of method should depend on the underlying data structure and the analytical needs.

8 April 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
KWKaiwen Wang
Kaiwen Wang
YYYuqiu Yang
Yuqiu Yang
FWFangjiang Wu
Fangjiang Wu
BSBing Song
Bing Song
XWXinlei Wang
Xinlei Wang
TWTao Wang
Tao Wang

20 June 2025 in bioRxiv
Verified
Preprint
Open access
KWKaiwen Wang
Kaiwen Wang
YYYuqiu Yang
Yuqiu Yang
YXYusen Xia
Yusen Xia
GXGuanghua Xiao
Guanghua Xiao
JLJohan Lim
Johan Lim
XWXinlei Wang
Xinlei Wang
With the rise of large-scale genomic studies, large gene lists targeting important diseases are increasingly common. While evaluating each study individually gives valuable insights on specific samples and study designs, the wealth of available evidence in the literature calls for robust and efficient meta-analytic methods. Crucially, the diverse assumptions and experimental protocols underlying different studies require a flexible but rigorous method for aggregation. To address these issues, we propose BiGER, a fast and accurate Bayesian rank aggregation method for the inference of latent global rankings. Unlike existing methods in the field, BiGER accommodates mixed gene lists with top-ranked and top-unranked genes as well as bottom-tied and missing genes, by design. Using a Bayesian hierarchical framework combined with variational inference, BiGER efficiently aggregates large-scale gene lists with high accuracy, while providing valuable insights into source-specific reliability for researchers. Through both simulated and real datasets, we show that BiGER is a useful tool for reliable meta-analysis in genomic studies.

2 July 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
BSBing Song
Bing Song
KWKaiwen Wang
Kaiwen Wang
SNSaiyang Na
Saiyang Na
JYJia Yao
Jia Yao
FFFarjana J Fattah
Farjana J Fattah
TWTao Wang
Tao Wang
The interaction between antigens and antibodies (B cell receptors, BCRs) is the key step underlying the function of the humoral immune system in various biological contexts. The capability to profile the landscape of antigen-binding affinity of a vast number of BCRs will provide a powerful tool to reveal novel insights at unprecedented levels and will yield powerful tools for translational development. However, current experimental approaches for profiling antibody-antigen interactions are costly and time-consuming, and can only achieve low-to-mid throughput. On the other hand, bioinformatics tools in the field of antibody informatics mostly focus on optimization of antibodies given known binding antigens, which is a very different research question and of limited scope. In this work, we developed an innovative Artificial Intelligence tool, Cmai, to address the prediction of the binding between antibodies and antigens that can be scaled to high-throughput sequencing data. Cmai achieved an AUROC of 0.91 in our validation cohort. We devised a biomarker metric based on the output from Cmai applied to high-throughput BCR sequencing data. We found that, during immune-related adverse events (irAEs) caused by immune-checkpoint inhibitor (ICI) treatment, the humoral immunity is preferentially responsive to intracellular antigens from the organs affected by the irAEs. In contrast, extracellular antigens on malignant tumor cells are inducing B cell infiltrations, and the infiltrating B cells have a greater tendency to co-localize with tumor cells expressing these antigens. We further found that the abundance of tumor antigen-targeting antibodies is predictive of ICI treatment response. Overall, Cmai and our biomarker approach filled in a gap that is not addressed by current antibody optimization works nor works such as AlphaFold3 that predict the structures of complexes of proteins that are known to bind.